Newsfeeds Archive - Spark Newswire

4 minute read

Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

February 9, 2:18 PM

Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter results.

AFRM

2 minute read

SPS Commerce Posts Upbeat Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Friday

By Avi Kapoor

February 9, 11:31 AM

U.S. stocks traded mixed, with the Nasdaq Composite gaining around 100 points on Friday. Shares of SPS Commerce, Inc. (NASDAQ: SPSC) rose sharply during Friday’s session following upbeat results.

1 minute read

Events
News

Centessa Pharmaceuticals Announced New Data From Additional 52-Weeks of Continuous Treatment From Third Year (Part 5) Of Ongoing Phase 2a Study Of SerpinPC For Treatment Of Hemophilia At 2023 ASH Meeting

By Charles Gross

December 10, 1:57 PM

Centessa Pharmaceuticals plc (NASDAQ:CNTA), today announced new data from an additional 52-weeks of continuous treatment from the third year (Part 5) of the ongoing Phase 2a study of SerpinPC for the treatment of

CNTA

1 minute read

Movers

12 Health Care Stocks Moving In Monday’s After-Market Session

By Benzinga Insights

November 27, 5:31 PM

Gainers SenesTech (NASDAQ:SNES) stock rose 42.0% to $2.67 during Monday’s after-market session. TC BioPharm (Holdings) (NASDAQ:TCBP) shares rose…

ACRX

2 minute read

Anaptys Expands Immune Cell Modulator Pipeline With Exclusive License To BDCA2 Modulator Antibody Portfolio From Centessa Pharmaceuticals; Anaptys Will Pay Centessa A One-Time Upfront Cash Payment Of $7M

By Benzinga Newsdesk

November 27, 5:16 PM

Anaptys licenses exclusive global development and commercialization rights to a potential best-in-class BDCA2 modulator portfolio IND filing to support clinical development of ANB101 in autoimmune and inflammatory

ANAB

2 minute read

Centessa Pharmaceuticals Announces Dosing Of First Subject In Registrational PRESent-3 Study Evaluating SerpinPC For The Treatment Of Hemophilia B With Inhibitors

By Benzinga Newsdesk

October 31, 8:06 AM

Centessa Pharmaceuticals plc (NASDAQ:CNTA), a clinical-stage pharmaceutical company focused on discovering and developing medicines that are transformational for patients, today announced the dosing of the first subject

CNTA

3 minute read

IBM, ServiceNow, Lennox, Morningstar And Other Big Stocks Moving Higher On Thursday

By Lisa Levin

October 26, 11:55 AM

U.S. stocks traded lower, with the Nasdaq Composite falling more than 90 points on Thursday. Here are some big stocks bucking the trend and recording gains in today’s session.

AOS

2 minute read

Analyst Ratings

Where Centessa Pharmaceuticals Stands With Analysts

By Benzinga Insights

August 15, 4:00 PM

Over the past 3 months, 5 analysts have published their opinion on Centessa Pharmaceuticals (NASDAQ:CNTA) stock. These analysts…

CNTA

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s After-Market Session

By Benzinga Insights

July 13, 5:38 PM

Gainers Ainos (NASDAQ:AIMD) shares increased by 84.9% to $1.35 during Thursday’s after-market session. At the close, Ainos’s trading…

ACAD

4 minute read

Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

July 12, 12:53 PM

Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.

ABCL